Company intelligence / Profile preview

Kips Bay Medical

Minneapolis, Minnesota, United Stateskipsbaymedical.com ↗

Ownership: Private
Employees: ~50
Development stage: Phase 2

Overview

The company developed the eSVS Mesh, an external support sleeve for saphenous vein grafts to improve outcomes in CABG surgery. Clinical feasibility trials were terminated after results did not meet expectations for U.S. regulatory advancement. The company was dissolved in 2015[4].

Therapeutic areas: Cardiovascular
Modalities: Medical device (external saphenous vein support mesh)
Industry: Implantable Medical Devices

Drug pipeline

2 assets

DM199

Phase 2/3

Indications: Acute ischemic stroke, Cardio-renal disease

1 more asset in the full pipeline.

Request access →

Partnerships

Not specified

Beyond the preview

Go deeper on Kips Bay Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kips Bay Medical.

Explore the full profile